DK2714042T3 - En analgetisk farmaceutisk sammensætning til oral administration - Google Patents
En analgetisk farmaceutisk sammensætning til oral administrationInfo
- Publication number
- DK2714042T3 DK2714042T3 DK12735347.2T DK12735347T DK2714042T3 DK 2714042 T3 DK2714042 T3 DK 2714042T3 DK 12735347 T DK12735347 T DK 12735347T DK 2714042 T3 DK2714042 T3 DK 2714042T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- oral administration
- analgesic pharmaceutical
- analgesic
- oral
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL39506911A PL395069A1 (pl) | 2011-05-31 | 2011-05-31 | Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego |
PCT/PL2012/050016 WO2012165985A1 (en) | 2011-05-31 | 2012-05-31 | An analgesic pharmaceutical composition for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2714042T3 true DK2714042T3 (da) | 2019-01-02 |
Family
ID=46513810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12735347.2T DK2714042T3 (da) | 2011-05-31 | 2012-05-31 | En analgetisk farmaceutisk sammensætning til oral administration |
Country Status (7)
Country | Link |
---|---|
US (1) | US9101577B2 (da) |
EP (1) | EP2714042B1 (da) |
DK (1) | DK2714042T3 (da) |
ES (1) | ES2708689T3 (da) |
HU (1) | HUE040419T2 (da) |
PL (2) | PL395069A1 (da) |
WO (1) | WO2012165985A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014237237A1 (en) * | 2013-03-15 | 2015-10-29 | Russell Jaffe | Soft gel encapsulation |
GB2607333A (en) * | 2021-06-03 | 2022-12-07 | Horopito Ltd | Pain relief composition |
EP4389120A1 (en) * | 2022-12-20 | 2024-06-26 | Inflacod Sp. z o.o. | An anti-inflammatory pharmaceutical composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2116257T3 (da) * | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
IL159156A0 (en) * | 2001-06-22 | 2004-06-01 | Millard Marsden Mershon | A gel forming composition containing a polyacrylic acid |
RU2284189C2 (ru) * | 2001-08-27 | 2006-09-27 | Киова Кемикал Индастри Ко., Лтд. | Антацидная и слабительная таблетка |
US20040048870A1 (en) * | 2002-09-06 | 2004-03-11 | Amir Ahmad A. | Composition for the prevention and treatment of migraine headaches |
JP2006522819A (ja) * | 2003-04-08 | 2006-10-05 | プロジェニックス ファーマシューティカルズ,インコーポレーテッド | 緩下薬および末梢オピオイドアンタゴニストを組み合わせた便秘の組み合わせ療法 |
US20070259033A1 (en) * | 2003-09-26 | 2007-11-08 | Evangeline Cruz | Controlled release formulations exhibiting an ascending rate of release |
US20080220064A1 (en) * | 2006-12-06 | 2008-09-11 | Ramesh Ketkar Anant | Extended release matrix formulations of morphine |
-
2011
- 2011-05-31 PL PL39506911A patent/PL395069A1/pl unknown
-
2012
- 2012-05-31 ES ES12735347T patent/ES2708689T3/es active Active
- 2012-05-31 DK DK12735347.2T patent/DK2714042T3/da active
- 2012-05-31 PL PL12735347T patent/PL2714042T3/pl unknown
- 2012-05-31 HU HUE12735347A patent/HUE040419T2/hu unknown
- 2012-05-31 EP EP12735347.2A patent/EP2714042B1/en active Active
- 2012-05-31 US US14/122,712 patent/US9101577B2/en active Active
- 2012-05-31 WO PCT/PL2012/050016 patent/WO2012165985A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ES2708689T3 (es) | 2019-04-10 |
EP2714042A1 (en) | 2014-04-09 |
HUE040419T2 (hu) | 2019-03-28 |
WO2012165985A1 (en) | 2012-12-06 |
PL2714042T3 (pl) | 2019-03-29 |
US20140127302A1 (en) | 2014-05-08 |
US9101577B2 (en) | 2015-08-11 |
EP2714042B1 (en) | 2018-08-29 |
PL395069A1 (pl) | 2012-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201500232B (it) | Dispositivo per la somministrazione de farmaci | |
DK2680832T3 (da) | Vandig farmaceutisk formulering af tapentadol til oral administration | |
DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
DK3527241T3 (da) | Indretning til administration af lægemiddel | |
DK2694038T3 (da) | Farmaceutisk sammensætning | |
BR112013017169A2 (pt) | composições farmacêuticas de ferro para administração oral | |
BR112014003052A2 (pt) | composições farmacêuticas | |
DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
DK3246018T3 (da) | Farmaceutisk sammensætning | |
EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
CO6930367A2 (es) | Composiciones farmaceúticas | |
SMT201600341B (it) | Soluzione per somministrazione orale | |
EE201300005A (et) | Ravimkoostis | |
BR112013012476A2 (pt) | formulações farmacêuticas contendo corticosteróides para administração tópica | |
CO6940426A2 (es) | Formulaciones farmacéuticas | |
DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
BRPI1007484A2 (pt) | composição farmacêutica para administração oral | |
BR112014009889A2 (pt) | compostos dissubstituídos, compostos e composição farmacêutica | |
EP2731605A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION | |
DK2542224T3 (da) | Oral farmaceutisk sammensætning indeholdende dabigatranetexilat | |
SMT201500005B (it) | Composizione framaceutica inalabile | |
CU24163B1 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
BR112014015885A2 (pt) | preparação farmacêutica | |
EP2668852A4 (en) | COMPOSITION FOR ORAL ADMINISTRATION |